tiprankstipranks
Trending News
More News >

Medicenna to Present Innovative Cancer Data at Conferences

Story Highlights
Medicenna to Present Innovative Cancer Data at Conferences

Medicenna Therapeutics Corp (TSE:MDNA) has released an update.

Confident Investing Starts Here:

Medicenna Therapeutics Corp. is set to present promising pre-clinical data on its innovative IL-2 Superkines, MDNA11, at two major oncology conferences. These presentations could attract investor interest as they highlight advancements in treating aggressive cancers like glioblastoma and breast cancer.

For further insights into TSE:MDNA stock, check out TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App